ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/11/2026
Back to search
Official data from USPTO
IMMUNOPRECISE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOPRECISE
ST13
US500000087754228Class
1, 40
Filing
87754228
Registration
6077423
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
03/12/2026
Trademark type
Word
Nice classes
1, 40
Filing date
01/12/2018
Registration date
06/16/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2020
Last transaction
03/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
01/01/2014
First use in commerce
01/01/2014
Drawing code
4
Owner type
03
Owner location
VICTORIA, CA
Examiner
WILKE, JOHN
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MINDWALK HOLDINGS CORP.
ImmunoPrecise Antibodies Ltd.
Representatives
ADAM K SACHAROFF Much Shelist, PC
Technical classification
Nice Classes
Class 1Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Antibodies for research usescientific diagnostic usediagnostic research usediagnostic medical research usediagnostic veterinary research useindustrial scientific useindustrial research useuse in industrial manufacturing processeslaboratory research usescientific use
Class 40
Biomanufacturing for othersgeneration and purification of antibodies for research usescientific diagnostic usediagnostic research usediagnostic medical research useindustrial scientific useindustrial research useuse in industrial manufacturing processeslaboratory research usescientific use; Biomanufacturing for othersgeneration and purification of antibodies for therapeutic medical usediagnostic veterinary use and therapeutic veterinary use
Publications
History of USPTO decisions and trademark events.
53 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/16/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2020
PUBO
PUBLISHED FOR OPPOSITION
03/31/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/18/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
02/18/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/18/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/18/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2019
GNRT
NON-FINAL ACTION E-MAILED
11/08/2019
CNRT
NON-FINAL ACTION WRITTEN
11/08/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/07/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/26/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/26/2019
ALIE
ASSIGNED TO LIE
09/19/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/13/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/19/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/19/2019
CNSL
SUSPENSION LETTER WRITTEN
03/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2019
ALIE
ASSIGNED TO LIE
03/18/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/14/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/14/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/14/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/29/2018
GNRT
NON-FINAL ACTION E-MAILED
10/29/2018
CNRT
NON-FINAL ACTION WRITTEN
10/29/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/10/2018
GNRT
NON-FINAL ACTION E-MAILED
08/10/2018
CNRT
NON-FINAL ACTION WRITTEN
08/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/25/2018
GNRT
NON-FINAL ACTION E-MAILED
04/25/2018
CNRT
NON-FINAL ACTION WRITTEN
04/25/2018
DOCK
ASSIGNED TO EXAMINER
04/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/26/2018
NWAP
NEW APPLICATION ENTERED
01/16/2018
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOPRECISE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.